nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C19—coronary artery disease	0.186	1	CbGaD
Loratadine—CYP2C8—Fenofibrate—coronary artery disease	0.0226	0.0399	CbGbCtD
Loratadine—CYP2C8—Gemfibrozil—coronary artery disease	0.018	0.0319	CbGbCtD
Loratadine—ABCB1—Ticagrelor—coronary artery disease	0.0171	0.0303	CbGbCtD
Loratadine—KCNH2—purkinje fiber—coronary artery disease	0.0169	0.438	CbGeAlD
Loratadine—CYP2C9—Fenofibrate—coronary artery disease	0.0157	0.0278	CbGbCtD
Loratadine—CYP2C8—Clopidogrel—coronary artery disease	0.0156	0.0276	CbGbCtD
Loratadine—CYP2C19—Gemfibrozil—coronary artery disease	0.0151	0.0267	CbGbCtD
Loratadine—CYP2C8—Pitavastatin—coronary artery disease	0.0137	0.0242	CbGbCtD
Loratadine—CYP2C19—Clopidogrel—coronary artery disease	0.0131	0.0232	CbGbCtD
Loratadine—CYP2C9—Gemfibrozil—coronary artery disease	0.0126	0.0222	CbGbCtD
Loratadine—CYP2C19—Telmisartan—coronary artery disease	0.0115	0.0203	CbGbCtD
Loratadine—CYP2C9—Clopidogrel—coronary artery disease	0.0109	0.0193	CbGbCtD
Loratadine—ABCB1—Clopidogrel—coronary artery disease	0.0106	0.0187	CbGbCtD
Loratadine—ABCB1—Perindopril—coronary artery disease	0.0106	0.0187	CbGbCtD
Loratadine—CYP3A4—Ticagrelor—coronary artery disease	0.0103	0.0181	CbGbCtD
Loratadine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00982	0.0174	CbGbCtD
Loratadine—CYP2C9—Pitavastatin—coronary artery disease	0.00954	0.0169	CbGbCtD
Loratadine—CYP2C8—Simvastatin—coronary artery disease	0.00937	0.0166	CbGbCtD
Loratadine—CYP2C9—Valsartan—coronary artery disease	0.00928	0.0164	CbGbCtD
Loratadine—ABCB1—Telmisartan—coronary artery disease	0.00925	0.0164	CbGbCtD
Loratadine—ABCB1—Pitavastatin—coronary artery disease	0.00925	0.0164	CbGbCtD
Loratadine—CYP2C19—Timolol—coronary artery disease	0.00925	0.0163	CbGbCtD
Loratadine—CYP2C8—Pravastatin—coronary artery disease	0.00917	0.0162	CbGbCtD
Loratadine—CYP2C8—Lovastatin—coronary artery disease	0.00917	0.0162	CbGbCtD
Loratadine—CYP3A4—Fenofibrate—coronary artery disease	0.00915	0.0162	CbGbCtD
Loratadine—ABCB1—Enalapril—coronary artery disease	0.00877	0.0155	CbGbCtD
Loratadine—ABCB1—Lisinopril—coronary artery disease	0.00877	0.0155	CbGbCtD
Loratadine—KCNH2—endocardium—coronary artery disease	0.00869	0.226	CbGeAlD
Loratadine—CYP2C19—Rosuvastatin—coronary artery disease	0.00846	0.0149	CbGbCtD
Loratadine—CYP2C8—Atorvastatin—coronary artery disease	0.00835	0.0148	CbGbCtD
Loratadine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00824	0.0146	CbGbCtD
Loratadine—CYP2C19—Simvastatin—coronary artery disease	0.00786	0.0139	CbGbCtD
Loratadine—CYP2C19—Lovastatin—coronary artery disease	0.00769	0.0136	CbGbCtD
Loratadine—CYP2C8—Losartan—coronary artery disease	0.00764	0.0135	CbGbCtD
Loratadine—CYP2D6—Niacin—coronary artery disease	0.00756	0.0134	CbGbCtD
Loratadine—ABCB1—Timolol—coronary artery disease	0.00746	0.0132	CbGbCtD
Loratadine—CYP3A4—Gemfibrozil—coronary artery disease	0.00732	0.0129	CbGbCtD
Loratadine—CYP2C9—cardial valve—coronary artery disease	0.00706	0.183	CbGeAlD
Loratadine—CYP2C9—Rosuvastatin—coronary artery disease	0.00703	0.0124	CbGbCtD
Loratadine—CYP2D6—Timolol—coronary artery disease	0.00703	0.0124	CbGbCtD
Loratadine—CYP2C19—Atorvastatin—coronary artery disease	0.00701	0.0124	CbGbCtD
Loratadine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00685	0.0121	CbGbCtD
Loratadine—ABCB1—Ezetimibe—coronary artery disease	0.00682	0.0121	CbGbCtD
Loratadine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00665	0.0118	CbGbCtD
Loratadine—ABCB1—Captopril—coronary artery disease	0.00657	0.0116	CbGbCtD
Loratadine—CYP2C9—Simvastatin—coronary artery disease	0.00654	0.0116	CbGbCtD
Loratadine—CYP2C19—Losartan—coronary artery disease	0.00641	0.0113	CbGbCtD
Loratadine—CYP2C9—Lovastatin—coronary artery disease	0.0064	0.0113	CbGbCtD
Loratadine—CYP2C9—Pravastatin—coronary artery disease	0.0064	0.0113	CbGbCtD
Loratadine—CYP3A4—Clopidogrel—coronary artery disease	0.00634	0.0112	CbGbCtD
Loratadine—ABCB1—Simvastatin—coronary artery disease	0.00634	0.0112	CbGbCtD
Loratadine—ABCB1—Lovastatin—coronary artery disease	0.00621	0.011	CbGbCtD
Loratadine—ABCB1—Pravastatin—coronary artery disease	0.00621	0.011	CbGbCtD
Loratadine—CYP2D6—Captopril—coronary artery disease	0.00619	0.0109	CbGbCtD
Loratadine—CYP2D6—Simvastatin—coronary artery disease	0.00598	0.0106	CbGbCtD
Loratadine—CYP3A4—Eplerenone—coronary artery disease	0.0059	0.0104	CbGbCtD
Loratadine—CYP2D6—Lovastatin—coronary artery disease	0.00585	0.0103	CbGbCtD
Loratadine—CYP2D6—Pravastatin—coronary artery disease	0.00585	0.0103	CbGbCtD
Loratadine—CYP2C9—Atorvastatin—coronary artery disease	0.00583	0.0103	CbGbCtD
Loratadine—ABCB1—Atorvastatin—coronary artery disease	0.00565	0.00999	CbGbCtD
Loratadine—CYP2C9—Losartan—coronary artery disease	0.00533	0.00942	CbGbCtD
Loratadine—CYP2D6—Atorvastatin—coronary artery disease	0.00533	0.00941	CbGbCtD
Loratadine—CYP3A4—Enalapril—coronary artery disease	0.00526	0.00929	CbGbCtD
Loratadine—ABCB1—Losartan—coronary artery disease	0.00517	0.00914	CbGbCtD
Loratadine—CYP3A4—Rosuvastatin—coronary artery disease	0.00409	0.00722	CbGbCtD
Loratadine—CYP3A4—Ezetimibe—coronary artery disease	0.00409	0.00722	CbGbCtD
Loratadine—CYP3A4—Simvastatin—coronary artery disease	0.0038	0.00672	CbGbCtD
Loratadine—CYP3A4—Pravastatin—coronary artery disease	0.00372	0.00657	CbGbCtD
Loratadine—CYP3A4—Lovastatin—coronary artery disease	0.00372	0.00657	CbGbCtD
Loratadine—CYP3A4—Atorvastatin—coronary artery disease	0.00339	0.00599	CbGbCtD
Loratadine—CYP3A4—Losartan—coronary artery disease	0.0031	0.00548	CbGbCtD
Loratadine—Ketotifen—PDE4B—coronary artery disease	0.000981	0.627	CrCbGaD
Loratadine—KCNH2—cardiac ventricle—coronary artery disease	0.000732	0.019	CbGeAlD
Loratadine—KCNH2—myocardium—coronary artery disease	0.000688	0.0179	CbGeAlD
Loratadine—Desloratadine—CYP2C19—coronary artery disease	0.000583	0.373	CrCbGaD
Loratadine—KCNH2—heart—coronary artery disease	0.00048	0.0125	CbGeAlD
Loratadine—KCNH2—cardiovascular system—coronary artery disease	0.000453	0.0118	CbGeAlD
Loratadine—KCNH2—cardiac atrium—coronary artery disease	0.000411	0.0107	CbGeAlD
Loratadine—CYP2C9—heart—coronary artery disease	0.00039	0.0101	CbGeAlD
Loratadine—CYP2C19—blood—coronary artery disease	0.000376	0.00976	CbGeAlD
Loratadine—CYP2C9—cardiovascular system—coronary artery disease	0.000368	0.00957	CbGeAlD
Loratadine—KCNH2—blood—coronary artery disease	0.000358	0.00931	CbGeAlD
Loratadine—CYP2C8—blood—coronary artery disease	0.000328	0.00852	CbGeAlD
Loratadine—CYP2C9—blood—coronary artery disease	0.000291	0.00756	CbGeAlD
Loratadine—CYP3A4—blood—coronary artery disease	0.000222	0.00577	CbGeAlD
Loratadine—CYP2D6—blood—coronary artery disease	0.000219	0.00568	CbGeAlD
Loratadine—ABCB1—heart—coronary artery disease	0.000211	0.00547	CbGeAlD
Loratadine—ABCB1—cardiovascular system—coronary artery disease	0.000199	0.00516	CbGeAlD
Loratadine—ABCB1—blood—coronary artery disease	0.000157	0.00408	CbGeAlD
Loratadine—Insomnia—Losartan—coronary artery disease	9.97e-05	0.000636	CcSEcCtD
Loratadine—Rash—Fenofibrate—coronary artery disease	9.96e-05	0.000636	CcSEcCtD
Loratadine—Dermatitis—Fenofibrate—coronary artery disease	9.95e-05	0.000635	CcSEcCtD
Loratadine—Loss of consciousness—Timolol—coronary artery disease	9.95e-05	0.000635	CcSEcCtD
Loratadine—Headache—Fenofibrate—coronary artery disease	9.9e-05	0.000632	CcSEcCtD
Loratadine—Paraesthesia—Losartan—coronary artery disease	9.89e-05	0.000632	CcSEcCtD
Loratadine—Gastrointestinal pain—Captopril—coronary artery disease	9.89e-05	0.000632	CcSEcCtD
Loratadine—Cough—Timolol—coronary artery disease	9.88e-05	0.000631	CcSEcCtD
Loratadine—Vomiting—Clopidogrel—coronary artery disease	9.87e-05	0.00063	CcSEcCtD
Loratadine—Diarrhoea—Simvastatin—coronary artery disease	9.87e-05	0.00063	CcSEcCtD
Loratadine—Gastrointestinal disorder—Furosemide—coronary artery disease	9.86e-05	0.00063	CcSEcCtD
Loratadine—Chest pain—Ramipril—coronary artery disease	9.86e-05	0.000629	CcSEcCtD
Loratadine—Myalgia—Ramipril—coronary artery disease	9.86e-05	0.000629	CcSEcCtD
Loratadine—Fatigue—Furosemide—coronary artery disease	9.85e-05	0.000629	CcSEcCtD
Loratadine—Body temperature increased—Telmisartan—coronary artery disease	9.84e-05	0.000628	CcSEcCtD
Loratadine—Abdominal pain—Telmisartan—coronary artery disease	9.84e-05	0.000628	CcSEcCtD
Loratadine—Vomiting—Lovastatin—coronary artery disease	9.81e-05	0.000626	CcSEcCtD
Loratadine—Somnolence—Losartan—coronary artery disease	9.8e-05	0.000626	CcSEcCtD
Loratadine—Dizziness—Eplerenone—coronary artery disease	9.79e-05	0.000625	CcSEcCtD
Loratadine—Rash—Clopidogrel—coronary artery disease	9.79e-05	0.000625	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.79e-05	0.000625	CcSEcCtD
Loratadine—Dermatitis—Clopidogrel—coronary artery disease	9.78e-05	0.000625	CcSEcCtD
Loratadine—Asthenia—Valsartan—coronary artery disease	9.78e-05	0.000624	CcSEcCtD
Loratadine—Hypertension—Timolol—coronary artery disease	9.77e-05	0.000624	CcSEcCtD
Loratadine—Pain—Furosemide—coronary artery disease	9.77e-05	0.000624	CcSEcCtD
Loratadine—Constipation—Furosemide—coronary artery disease	9.77e-05	0.000624	CcSEcCtD
Loratadine—Ill-defined disorder—Lisinopril—coronary artery disease	9.74e-05	0.000622	CcSEcCtD
Loratadine—Discomfort—Ramipril—coronary artery disease	9.74e-05	0.000622	CcSEcCtD
Loratadine—Asthenia—Olmesartan—coronary artery disease	9.73e-05	0.000621	CcSEcCtD
Loratadine—Headache—Clopidogrel—coronary artery disease	9.73e-05	0.000621	CcSEcCtD
Loratadine—Rash—Lovastatin—coronary artery disease	9.73e-05	0.000621	CcSEcCtD
Loratadine—Dermatitis—Lovastatin—coronary artery disease	9.72e-05	0.00062	CcSEcCtD
Loratadine—Dyspepsia—Losartan—coronary artery disease	9.7e-05	0.000619	CcSEcCtD
Loratadine—Feeling abnormal—Perindopril—coronary artery disease	9.68e-05	0.000618	CcSEcCtD
Loratadine—Headache—Lovastatin—coronary artery disease	9.66e-05	0.000617	CcSEcCtD
Loratadine—Dry mouth—Ramipril—coronary artery disease	9.64e-05	0.000616	CcSEcCtD
Loratadine—Chest pain—Timolol—coronary artery disease	9.64e-05	0.000615	CcSEcCtD
Loratadine—Myalgia—Timolol—coronary artery disease	9.64e-05	0.000615	CcSEcCtD
Loratadine—Vomiting—Ezetimibe—coronary artery disease	9.62e-05	0.000614	CcSEcCtD
Loratadine—Gastrointestinal pain—Perindopril—coronary artery disease	9.61e-05	0.000613	CcSEcCtD
Loratadine—Angioedema—Lisinopril—coronary artery disease	9.59e-05	0.000613	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.57e-05	0.000611	CcSEcCtD
Loratadine—Body temperature increased—Captopril—coronary artery disease	9.57e-05	0.000611	CcSEcCtD
Loratadine—Abdominal pain—Captopril—coronary artery disease	9.57e-05	0.000611	CcSEcCtD
Loratadine—Dizziness—Simvastatin—coronary artery disease	9.54e-05	0.000609	CcSEcCtD
Loratadine—Rash—Ezetimibe—coronary artery disease	9.54e-05	0.000609	CcSEcCtD
Loratadine—Dermatitis—Ezetimibe—coronary artery disease	9.53e-05	0.000609	CcSEcCtD
Loratadine—Discomfort—Timolol—coronary artery disease	9.52e-05	0.000608	CcSEcCtD
Loratadine—Asthenia—Niacin—coronary artery disease	9.5e-05	0.000607	CcSEcCtD
Loratadine—Fatigue—Losartan—coronary artery disease	9.5e-05	0.000607	CcSEcCtD
Loratadine—Headache—Ezetimibe—coronary artery disease	9.48e-05	0.000605	CcSEcCtD
Loratadine—Malaise—Lisinopril—coronary artery disease	9.47e-05	0.000605	CcSEcCtD
Loratadine—Anaphylactic shock—Ramipril—coronary artery disease	9.45e-05	0.000603	CcSEcCtD
Loratadine—Dry mouth—Timolol—coronary artery disease	9.42e-05	0.000602	CcSEcCtD
Loratadine—Pain—Losartan—coronary artery disease	9.42e-05	0.000602	CcSEcCtD
Loratadine—Constipation—Losartan—coronary artery disease	9.42e-05	0.000602	CcSEcCtD
Loratadine—Syncope—Lisinopril—coronary artery disease	9.42e-05	0.000601	CcSEcCtD
Loratadine—Vomiting—Eplerenone—coronary artery disease	9.41e-05	0.000601	CcSEcCtD
Loratadine—Feeling abnormal—Furosemide—coronary artery disease	9.41e-05	0.000601	CcSEcCtD
Loratadine—Nausea—Fenofibrate—coronary artery disease	9.38e-05	0.000599	CcSEcCtD
Loratadine—Asthenia—Pravastatin—coronary artery disease	9.36e-05	0.000598	CcSEcCtD
Loratadine—Gastrointestinal pain—Furosemide—coronary artery disease	9.34e-05	0.000596	CcSEcCtD
Loratadine—Rash—Eplerenone—coronary artery disease	9.34e-05	0.000596	CcSEcCtD
Loratadine—Dermatitis—Eplerenone—coronary artery disease	9.33e-05	0.000596	CcSEcCtD
Loratadine—Diarrhoea—Valsartan—coronary artery disease	9.32e-05	0.000595	CcSEcCtD
Loratadine—Shock—Ramipril—coronary artery disease	9.3e-05	0.000594	CcSEcCtD
Loratadine—Abdominal pain—Perindopril—coronary artery disease	9.29e-05	0.000593	CcSEcCtD
Loratadine—Body temperature increased—Perindopril—coronary artery disease	9.29e-05	0.000593	CcSEcCtD
Loratadine—Palpitations—Lisinopril—coronary artery disease	9.28e-05	0.000592	CcSEcCtD
Loratadine—Diarrhoea—Olmesartan—coronary artery disease	9.28e-05	0.000592	CcSEcCtD
Loratadine—Headache—Eplerenone—coronary artery disease	9.28e-05	0.000592	CcSEcCtD
Loratadine—Nervous system disorder—Ramipril—coronary artery disease	9.27e-05	0.000592	CcSEcCtD
Loratadine—Anaphylactic shock—Timolol—coronary artery disease	9.24e-05	0.00059	CcSEcCtD
Loratadine—Loss of consciousness—Lisinopril—coronary artery disease	9.23e-05	0.000589	CcSEcCtD
Loratadine—Nausea—Clopidogrel—coronary artery disease	9.22e-05	0.000589	CcSEcCtD
Loratadine—Tachycardia—Ramipril—coronary artery disease	9.22e-05	0.000589	CcSEcCtD
Loratadine—Skin disorder—Ramipril—coronary artery disease	9.18e-05	0.000586	CcSEcCtD
Loratadine—Vomiting—Simvastatin—coronary artery disease	9.17e-05	0.000586	CcSEcCtD
Loratadine—Cough—Lisinopril—coronary artery disease	9.16e-05	0.000585	CcSEcCtD
Loratadine—Nausea—Lovastatin—coronary artery disease	9.16e-05	0.000585	CcSEcCtD
Loratadine—Rash—Simvastatin—coronary artery disease	9.1e-05	0.000581	CcSEcCtD
Loratadine—Dermatitis—Simvastatin—coronary artery disease	9.09e-05	0.00058	CcSEcCtD
Loratadine—Asthenia—Trandolapril—coronary artery disease	9.09e-05	0.00058	CcSEcCtD
Loratadine—Shock—Timolol—coronary artery disease	9.09e-05	0.00058	CcSEcCtD
Loratadine—Feeling abnormal—Losartan—coronary artery disease	9.08e-05	0.00058	CcSEcCtD
Loratadine—Diarrhoea—Niacin—coronary artery disease	9.06e-05	0.000579	CcSEcCtD
Loratadine—Nervous system disorder—Timolol—coronary artery disease	9.06e-05	0.000578	CcSEcCtD
Loratadine—Asthenia—Enalapril—coronary artery disease	9.05e-05	0.000578	CcSEcCtD
Loratadine—Headache—Simvastatin—coronary artery disease	9.04e-05	0.000577	CcSEcCtD
Loratadine—Abdominal pain—Furosemide—coronary artery disease	9.03e-05	0.000577	CcSEcCtD
Loratadine—Body temperature increased—Furosemide—coronary artery disease	9.03e-05	0.000577	CcSEcCtD
Loratadine—Gastrointestinal pain—Losartan—coronary artery disease	9.01e-05	0.000575	CcSEcCtD
Loratadine—Dizziness—Valsartan—coronary artery disease	9.01e-05	0.000575	CcSEcCtD
Loratadine—Nausea—Ezetimibe—coronary artery disease	8.99e-05	0.000574	CcSEcCtD
Loratadine—Skin disorder—Timolol—coronary artery disease	8.97e-05	0.000573	CcSEcCtD
Loratadine—Dizziness—Olmesartan—coronary artery disease	8.97e-05	0.000573	CcSEcCtD
Loratadine—Chest pain—Lisinopril—coronary artery disease	8.94e-05	0.000571	CcSEcCtD
Loratadine—Myalgia—Lisinopril—coronary artery disease	8.94e-05	0.000571	CcSEcCtD
Loratadine—Asthenia—Telmisartan—coronary artery disease	8.93e-05	0.00057	CcSEcCtD
Loratadine—Diarrhoea—Pravastatin—coronary artery disease	8.92e-05	0.00057	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.88e-05	0.000567	CcSEcCtD
Loratadine—Discomfort—Lisinopril—coronary artery disease	8.83e-05	0.000564	CcSEcCtD
Loratadine—Hypotension—Ramipril—coronary artery disease	8.83e-05	0.000564	CcSEcCtD
Loratadine—Nausea—Eplerenone—coronary artery disease	8.8e-05	0.000562	CcSEcCtD
Loratadine—Dizziness—Niacin—coronary artery disease	8.76e-05	0.000559	CcSEcCtD
Loratadine—Dry mouth—Lisinopril—coronary artery disease	8.74e-05	0.000558	CcSEcCtD
Loratadine—Abdominal pain—Losartan—coronary artery disease	8.71e-05	0.000556	CcSEcCtD
Loratadine—Body temperature increased—Losartan—coronary artery disease	8.71e-05	0.000556	CcSEcCtD
Loratadine—Asthenia—Captopril—coronary artery disease	8.68e-05	0.000554	CcSEcCtD
Loratadine—Diarrhoea—Trandolapril—coronary artery disease	8.67e-05	0.000553	CcSEcCtD
Loratadine—Vomiting—Valsartan—coronary artery disease	8.66e-05	0.000553	CcSEcCtD
Loratadine—Diarrhoea—Enalapril—coronary artery disease	8.63e-05	0.000551	CcSEcCtD
Loratadine—Hypotension—Timolol—coronary artery disease	8.63e-05	0.000551	CcSEcCtD
Loratadine—Dizziness—Pravastatin—coronary artery disease	8.63e-05	0.000551	CcSEcCtD
Loratadine—Vomiting—Olmesartan—coronary artery disease	8.62e-05	0.000551	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.61e-05	0.00055	CcSEcCtD
Loratadine—Rash—Valsartan—coronary artery disease	8.59e-05	0.000549	CcSEcCtD
Loratadine—Dermatitis—Valsartan—coronary artery disease	8.58e-05	0.000548	CcSEcCtD
Loratadine—Nausea—Simvastatin—coronary artery disease	8.57e-05	0.000547	CcSEcCtD
Loratadine—Anaphylactic shock—Lisinopril—coronary artery disease	8.57e-05	0.000547	CcSEcCtD
Loratadine—Rash—Olmesartan—coronary artery disease	8.55e-05	0.000546	CcSEcCtD
Loratadine—Insomnia—Ramipril—coronary artery disease	8.55e-05	0.000546	CcSEcCtD
Loratadine—Dermatitis—Olmesartan—coronary artery disease	8.54e-05	0.000545	CcSEcCtD
Loratadine—Headache—Valsartan—coronary artery disease	8.54e-05	0.000545	CcSEcCtD
Loratadine—Diarrhoea—Telmisartan—coronary artery disease	8.51e-05	0.000544	CcSEcCtD
Loratadine—Headache—Olmesartan—coronary artery disease	8.49e-05	0.000542	CcSEcCtD
Loratadine—Paraesthesia—Ramipril—coronary artery disease	8.48e-05	0.000542	CcSEcCtD
Loratadine—Shock—Lisinopril—coronary artery disease	8.43e-05	0.000538	CcSEcCtD
Loratadine—Asthenia—Perindopril—coronary artery disease	8.43e-05	0.000538	CcSEcCtD
Loratadine—Vomiting—Niacin—coronary artery disease	8.42e-05	0.000538	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Timolol—coronary artery disease	8.42e-05	0.000537	CcSEcCtD
Loratadine—Somnolence—Ramipril—coronary artery disease	8.4e-05	0.000536	CcSEcCtD
Loratadine—Dizziness—Trandolapril—coronary artery disease	8.38e-05	0.000535	CcSEcCtD
Loratadine—Tachycardia—Lisinopril—coronary artery disease	8.36e-05	0.000534	CcSEcCtD
Loratadine—Insomnia—Timolol—coronary artery disease	8.35e-05	0.000533	CcSEcCtD
Loratadine—Rash—Niacin—coronary artery disease	8.35e-05	0.000533	CcSEcCtD
Loratadine—Dermatitis—Niacin—coronary artery disease	8.35e-05	0.000533	CcSEcCtD
Loratadine—Dizziness—Enalapril—coronary artery disease	8.34e-05	0.000533	CcSEcCtD
Loratadine—Skin disorder—Lisinopril—coronary artery disease	8.32e-05	0.000531	CcSEcCtD
Loratadine—Dyspepsia—Ramipril—coronary artery disease	8.32e-05	0.000531	CcSEcCtD
Loratadine—Headache—Niacin—coronary artery disease	8.3e-05	0.00053	CcSEcCtD
Loratadine—Paraesthesia—Timolol—coronary artery disease	8.29e-05	0.00053	CcSEcCtD
Loratadine—Vomiting—Pravastatin—coronary artery disease	8.29e-05	0.00053	CcSEcCtD
Loratadine—Diarrhoea—Captopril—coronary artery disease	8.28e-05	0.000529	CcSEcCtD
Loratadine—Dizziness—Telmisartan—coronary artery disease	8.23e-05	0.000525	CcSEcCtD
Loratadine—Rash—Pravastatin—coronary artery disease	8.22e-05	0.000525	CcSEcCtD
Loratadine—Dermatitis—Pravastatin—coronary artery disease	8.22e-05	0.000525	CcSEcCtD
Loratadine—Somnolence—Timolol—coronary artery disease	8.21e-05	0.000524	CcSEcCtD
Loratadine—Asthenia—Furosemide—coronary artery disease	8.19e-05	0.000523	CcSEcCtD
Loratadine—Headache—Pravastatin—coronary artery disease	8.17e-05	0.000522	CcSEcCtD
Loratadine—Gastrointestinal disorder—Ramipril—coronary artery disease	8.16e-05	0.000521	CcSEcCtD
Loratadine—Fatigue—Ramipril—coronary artery disease	8.15e-05	0.00052	CcSEcCtD
Loratadine—Dyspepsia—Timolol—coronary artery disease	8.13e-05	0.000519	CcSEcCtD
Loratadine—Nausea—Valsartan—coronary artery disease	8.09e-05	0.000517	CcSEcCtD
Loratadine—Constipation—Ramipril—coronary artery disease	8.08e-05	0.000516	CcSEcCtD
Loratadine—Nausea—Olmesartan—coronary artery disease	8.05e-05	0.000514	CcSEcCtD
Loratadine—Vomiting—Trandolapril—coronary artery disease	8.05e-05	0.000514	CcSEcCtD
Loratadine—Diarrhoea—Perindopril—coronary artery disease	8.04e-05	0.000513	CcSEcCtD
Loratadine—Vomiting—Enalapril—coronary artery disease	8.02e-05	0.000512	CcSEcCtD
Loratadine—Hypotension—Lisinopril—coronary artery disease	8.01e-05	0.000511	CcSEcCtD
Loratadine—Dizziness—Captopril—coronary artery disease	8e-05	0.000511	CcSEcCtD
Loratadine—Rash—Trandolapril—coronary artery disease	7.99e-05	0.00051	CcSEcCtD
Loratadine—Dermatitis—Trandolapril—coronary artery disease	7.98e-05	0.00051	CcSEcCtD
Loratadine—Gastrointestinal disorder—Timolol—coronary artery disease	7.97e-05	0.000509	CcSEcCtD
Loratadine—Fatigue—Timolol—coronary artery disease	7.96e-05	0.000509	CcSEcCtD
Loratadine—Rash—Enalapril—coronary artery disease	7.95e-05	0.000508	CcSEcCtD
Loratadine—Dermatitis—Enalapril—coronary artery disease	7.95e-05	0.000507	CcSEcCtD
Loratadine—Headache—Trandolapril—coronary artery disease	7.94e-05	0.000507	CcSEcCtD
Loratadine—Vomiting—Telmisartan—coronary artery disease	7.91e-05	0.000505	CcSEcCtD
Loratadine—Asthenia—Losartan—coronary artery disease	7.91e-05	0.000505	CcSEcCtD
Loratadine—Headache—Enalapril—coronary artery disease	7.9e-05	0.000505	CcSEcCtD
Loratadine—Pain—Timolol—coronary artery disease	7.9e-05	0.000504	CcSEcCtD
Loratadine—Nausea—Niacin—coronary artery disease	7.87e-05	0.000502	CcSEcCtD
Loratadine—Rash—Telmisartan—coronary artery disease	7.85e-05	0.000501	CcSEcCtD
Loratadine—Dermatitis—Telmisartan—coronary artery disease	7.84e-05	0.000501	CcSEcCtD
Loratadine—Diarrhoea—Furosemide—coronary artery disease	7.81e-05	0.000499	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.81e-05	0.000499	CcSEcCtD
Loratadine—Headache—Telmisartan—coronary artery disease	7.8e-05	0.000498	CcSEcCtD
Loratadine—Feeling abnormal—Ramipril—coronary artery disease	7.79e-05	0.000497	CcSEcCtD
Loratadine—Dizziness—Perindopril—coronary artery disease	7.77e-05	0.000496	CcSEcCtD
Loratadine—Insomnia—Lisinopril—coronary artery disease	7.75e-05	0.000495	CcSEcCtD
Loratadine—Nausea—Pravastatin—coronary artery disease	7.75e-05	0.000495	CcSEcCtD
Loratadine—Gastrointestinal pain—Ramipril—coronary artery disease	7.73e-05	0.000493	CcSEcCtD
Loratadine—Paraesthesia—Lisinopril—coronary artery disease	7.69e-05	0.000491	CcSEcCtD
Loratadine—Vomiting—Captopril—coronary artery disease	7.69e-05	0.000491	CcSEcCtD
Loratadine—Rash—Captopril—coronary artery disease	7.63e-05	0.000487	CcSEcCtD
Loratadine—Dermatitis—Captopril—coronary artery disease	7.62e-05	0.000487	CcSEcCtD
Loratadine—Somnolence—Lisinopril—coronary artery disease	7.62e-05	0.000486	CcSEcCtD
Loratadine—Feeling abnormal—Timolol—coronary artery disease	7.61e-05	0.000486	CcSEcCtD
Loratadine—Headache—Captopril—coronary artery disease	7.58e-05	0.000484	CcSEcCtD
Loratadine—Gastrointestinal pain—Timolol—coronary artery disease	7.55e-05	0.000482	CcSEcCtD
Loratadine—Dizziness—Furosemide—coronary artery disease	7.55e-05	0.000482	CcSEcCtD
Loratadine—Dyspepsia—Lisinopril—coronary artery disease	7.54e-05	0.000482	CcSEcCtD
Loratadine—Diarrhoea—Losartan—coronary artery disease	7.54e-05	0.000481	CcSEcCtD
Loratadine—Nausea—Trandolapril—coronary artery disease	7.52e-05	0.00048	CcSEcCtD
Loratadine—Nausea—Enalapril—coronary artery disease	7.49e-05	0.000479	CcSEcCtD
Loratadine—Vomiting—Perindopril—coronary artery disease	7.47e-05	0.000477	CcSEcCtD
Loratadine—Abdominal pain—Ramipril—coronary artery disease	7.47e-05	0.000477	CcSEcCtD
Loratadine—Body temperature increased—Ramipril—coronary artery disease	7.47e-05	0.000477	CcSEcCtD
Loratadine—Rash—Perindopril—coronary artery disease	7.41e-05	0.000473	CcSEcCtD
Loratadine—Dermatitis—Perindopril—coronary artery disease	7.4e-05	0.000473	CcSEcCtD
Loratadine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.4e-05	0.000472	CcSEcCtD
Loratadine—Nausea—Telmisartan—coronary artery disease	7.39e-05	0.000472	CcSEcCtD
Loratadine—Fatigue—Lisinopril—coronary artery disease	7.39e-05	0.000472	CcSEcCtD
Loratadine—Headache—Perindopril—coronary artery disease	7.36e-05	0.00047	CcSEcCtD
Loratadine—Pain—Lisinopril—coronary artery disease	7.33e-05	0.000468	CcSEcCtD
Loratadine—Constipation—Lisinopril—coronary artery disease	7.33e-05	0.000468	CcSEcCtD
Loratadine—Abdominal pain—Timolol—coronary artery disease	7.3e-05	0.000466	CcSEcCtD
Loratadine—Body temperature increased—Timolol—coronary artery disease	7.3e-05	0.000466	CcSEcCtD
Loratadine—Dizziness—Losartan—coronary artery disease	7.29e-05	0.000465	CcSEcCtD
Loratadine—Vomiting—Furosemide—coronary artery disease	7.26e-05	0.000464	CcSEcCtD
Loratadine—Rash—Furosemide—coronary artery disease	7.2e-05	0.00046	CcSEcCtD
Loratadine—Dermatitis—Furosemide—coronary artery disease	7.19e-05	0.000459	CcSEcCtD
Loratadine—Nausea—Captopril—coronary artery disease	7.19e-05	0.000459	CcSEcCtD
Loratadine—Headache—Furosemide—coronary artery disease	7.15e-05	0.000457	CcSEcCtD
Loratadine—Feeling abnormal—Lisinopril—coronary artery disease	7.06e-05	0.000451	CcSEcCtD
Loratadine—Gastrointestinal pain—Lisinopril—coronary artery disease	7.01e-05	0.000447	CcSEcCtD
Loratadine—Vomiting—Losartan—coronary artery disease	7.01e-05	0.000447	CcSEcCtD
Loratadine—Nausea—Perindopril—coronary artery disease	6.98e-05	0.000446	CcSEcCtD
Loratadine—Rash—Losartan—coronary artery disease	6.95e-05	0.000444	CcSEcCtD
Loratadine—Dermatitis—Losartan—coronary artery disease	6.94e-05	0.000443	CcSEcCtD
Loratadine—Headache—Losartan—coronary artery disease	6.9e-05	0.000441	CcSEcCtD
Loratadine—Nausea—Furosemide—coronary artery disease	6.78e-05	0.000433	CcSEcCtD
Loratadine—Asthenia—Ramipril—coronary artery disease	6.78e-05	0.000433	CcSEcCtD
Loratadine—Body temperature increased—Lisinopril—coronary artery disease	6.77e-05	0.000433	CcSEcCtD
Loratadine—Abdominal pain—Lisinopril—coronary artery disease	6.77e-05	0.000433	CcSEcCtD
Loratadine—Asthenia—Timolol—coronary artery disease	6.63e-05	0.000423	CcSEcCtD
Loratadine—Nausea—Losartan—coronary artery disease	6.55e-05	0.000418	CcSEcCtD
Loratadine—Diarrhoea—Ramipril—coronary artery disease	6.46e-05	0.000413	CcSEcCtD
Loratadine—Diarrhoea—Timolol—coronary artery disease	6.32e-05	0.000404	CcSEcCtD
Loratadine—Dizziness—Ramipril—coronary artery disease	6.25e-05	0.000399	CcSEcCtD
Loratadine—Asthenia—Lisinopril—coronary artery disease	6.15e-05	0.000393	CcSEcCtD
Loratadine—Dizziness—Timolol—coronary artery disease	6.11e-05	0.00039	CcSEcCtD
Loratadine—Vomiting—Ramipril—coronary artery disease	6.01e-05	0.000384	CcSEcCtD
Loratadine—Rash—Ramipril—coronary artery disease	5.96e-05	0.00038	CcSEcCtD
Loratadine—Dermatitis—Ramipril—coronary artery disease	5.95e-05	0.00038	CcSEcCtD
Loratadine—Headache—Ramipril—coronary artery disease	5.92e-05	0.000378	CcSEcCtD
Loratadine—Vomiting—Timolol—coronary artery disease	5.87e-05	0.000375	CcSEcCtD
Loratadine—Diarrhoea—Lisinopril—coronary artery disease	5.86e-05	0.000374	CcSEcCtD
Loratadine—Rash—Timolol—coronary artery disease	5.82e-05	0.000372	CcSEcCtD
Loratadine—Dermatitis—Timolol—coronary artery disease	5.82e-05	0.000372	CcSEcCtD
Loratadine—Headache—Timolol—coronary artery disease	5.79e-05	0.00037	CcSEcCtD
Loratadine—Dizziness—Lisinopril—coronary artery disease	5.67e-05	0.000362	CcSEcCtD
Loratadine—Nausea—Ramipril—coronary artery disease	5.61e-05	0.000358	CcSEcCtD
Loratadine—Nausea—Timolol—coronary artery disease	5.49e-05	0.00035	CcSEcCtD
Loratadine—Vomiting—Lisinopril—coronary artery disease	5.45e-05	0.000348	CcSEcCtD
Loratadine—Rash—Lisinopril—coronary artery disease	5.4e-05	0.000345	CcSEcCtD
Loratadine—Dermatitis—Lisinopril—coronary artery disease	5.4e-05	0.000345	CcSEcCtD
Loratadine—Headache—Lisinopril—coronary artery disease	5.37e-05	0.000343	CcSEcCtD
Loratadine—Nausea—Lisinopril—coronary artery disease	5.09e-05	0.000325	CcSEcCtD
Loratadine—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.52e-06	8.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOB—coronary artery disease	4.51e-06	8.82e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMB5—coronary artery disease	4.48e-06	8.76e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMA6—coronary artery disease	4.48e-06	8.76e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	4.47e-06	8.75e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.47e-06	8.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	4.45e-06	8.7e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—coronary artery disease	4.44e-06	8.68e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CTGF—coronary artery disease	4.42e-06	8.63e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL5—coronary artery disease	4.41e-06	8.61e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CTGF—coronary artery disease	4.38e-06	8.56e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.38e-06	8.56e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT2—coronary artery disease	4.38e-06	8.56e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PLCB1—coronary artery disease	4.38e-06	8.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CSF2—coronary artery disease	4.34e-06	8.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF1—coronary artery disease	4.34e-06	8.49e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMGCR—coronary artery disease	4.34e-06	8.48e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT2—coronary artery disease	4.34e-06	8.48e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX2—coronary artery disease	4.33e-06	8.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA2—coronary artery disease	4.33e-06	8.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.33e-06	8.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LPL—coronary artery disease	4.31e-06	8.42e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.29e-06	8.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.27e-06	8.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX4—coronary artery disease	4.27e-06	8.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.27e-06	8.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HK1—coronary artery disease	4.27e-06	8.36e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PLCB1—coronary artery disease	4.27e-06	8.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	4.27e-06	8.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	4.27e-06	8.35e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCA1—coronary artery disease	4.24e-06	8.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HADHA—coronary artery disease	4.22e-06	8.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.17e-06	8.16e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	4.16e-06	8.14e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ABCA1—coronary artery disease	4.14e-06	8.09e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—coronary artery disease	4.13e-06	8.08e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPA—coronary artery disease	4.13e-06	8.07e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GOT1—coronary artery disease	4.11e-06	8.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GGT1—coronary artery disease	4.11e-06	8.03e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	4.1e-06	8.01e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—coronary artery disease	4.08e-06	7.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	4.06e-06	7.94e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	4.04e-06	7.9e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.02e-06	7.87e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAT—coronary artery disease	4.02e-06	7.86e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GGT1—coronary artery disease	4.01e-06	7.84e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GOT1—coronary artery disease	4.01e-06	7.84e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLCB3—coronary artery disease	4e-06	7.82e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.99e-06	7.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3.97e-06	7.76e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.96e-06	7.74e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.91e-06	7.65e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOB—coronary artery disease	3.9e-06	7.64e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.9e-06	7.63e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	3.88e-06	7.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.88e-06	7.59e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—C3—coronary artery disease	3.88e-06	7.58e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.87e-06	7.56e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.81e-06	7.45e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.8e-06	7.43e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GGT1—coronary artery disease	3.78e-06	7.39e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT1—coronary artery disease	3.78e-06	7.39e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GGT1—coronary artery disease	3.75e-06	7.32e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT1—coronary artery disease	3.75e-06	7.32e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LPL—coronary artery disease	3.73e-06	7.29e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	3.7e-06	7.23e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.69e-06	7.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AGT—coronary artery disease	3.69e-06	7.21e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3.66e-06	7.15e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—coronary artery disease	3.64e-06	7.11e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—coronary artery disease	3.64e-06	7.11e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—coronary artery disease	3.61e-06	7.06e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—coronary artery disease	3.61e-06	7.06e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—coronary artery disease	3.6e-06	7.04e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—VCAN—coronary artery disease	3.59e-06	7.02e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAT—coronary artery disease	3.59e-06	7.02e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOA1—coronary artery disease	3.57e-06	6.98e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.57e-06	6.98e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.56e-06	6.97e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—coronary artery disease	3.55e-06	6.94e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CD36—coronary artery disease	3.54e-06	6.93e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—coronary artery disease	3.54e-06	6.92e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	3.51e-06	6.87e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAT—coronary artery disease	3.5e-06	6.85e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.5e-06	6.84e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOB—coronary artery disease	3.49e-06	6.82e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—DCN—coronary artery disease	3.46e-06	6.76e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—coronary artery disease	3.45e-06	6.74e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—F2—coronary artery disease	3.41e-06	6.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—coronary artery disease	3.41e-06	6.66e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOB—coronary artery disease	3.4e-06	6.65e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.39e-06	6.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	3.39e-06	6.63e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.39e-06	6.63e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.37e-06	6.58e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	3.36e-06	6.58e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—coronary artery disease	3.36e-06	6.58e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.36e-06	6.57e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.36e-06	6.56e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.35e-06	6.54e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	3.33e-06	6.52e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LPL—coronary artery disease	3.33e-06	6.51e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—coronary artery disease	3.32e-06	6.49e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—coronary artery disease	3.31e-06	6.47e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAT—coronary artery disease	3.3e-06	6.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.28e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.28e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.28e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.28e-06	6.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAT—coronary artery disease	3.27e-06	6.4e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.26e-06	6.37e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—coronary artery disease	3.26e-06	6.37e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LPL—coronary artery disease	3.25e-06	6.35e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—coronary artery disease	3.25e-06	6.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.24e-06	6.33e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOB—coronary artery disease	3.21e-06	6.27e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.2e-06	6.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.2e-06	6.26e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AGT—coronary artery disease	3.19e-06	6.24e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOB—coronary artery disease	3.18e-06	6.21e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—coronary artery disease	3.17e-06	6.2e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.16e-06	6.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CETP—coronary artery disease	3.16e-06	6.19e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CD36—coronary artery disease	3.16e-06	6.18e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.13e-06	6.12e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	3.13e-06	6.11e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—coronary artery disease	3.13e-06	6.11e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.12e-06	6.11e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.12e-06	6.1e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—POMC—coronary artery disease	3.1e-06	6.07e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREB1—coronary artery disease	3.1e-06	6.07e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.09e-06	6.04e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOA1—coronary artery disease	3.09e-06	6.04e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CD36—coronary artery disease	3.09e-06	6.03e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LPL—coronary artery disease	3.06e-06	5.99e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.05e-06	5.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL2—coronary artery disease	3.04e-06	5.93e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LPL—coronary artery disease	3.03e-06	5.93e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6R—coronary artery disease	3.03e-06	5.92e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—coronary artery disease	3e-06	5.86e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.99e-06	5.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.98e-06	5.83e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.97e-06	5.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—coronary artery disease	2.96e-06	5.79e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.96e-06	5.78e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.96e-06	5.78e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.96e-06	5.78e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—coronary artery disease	2.92e-06	5.72e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CD36—coronary artery disease	2.91e-06	5.69e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.89e-06	5.65e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CD36—coronary artery disease	2.88e-06	5.64e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.87e-06	5.62e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.86e-06	5.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.86e-06	5.59e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.85e-06	5.57e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AGT—coronary artery disease	2.85e-06	5.57e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.84e-06	5.55e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.83e-06	5.54e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—coronary artery disease	2.79e-06	5.45e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AGT—coronary artery disease	2.78e-06	5.43e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOA1—coronary artery disease	2.76e-06	5.39e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.76e-06	5.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.74e-06	5.36e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.73e-06	5.34e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—coronary artery disease	2.72e-06	5.32e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—coronary artery disease	2.72e-06	5.32e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.71e-06	5.29e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOA1—coronary artery disease	2.69e-06	5.26e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—POMC—coronary artery disease	2.68e-06	5.25e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.64e-06	5.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.63e-06	5.14e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.63e-06	5.14e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AGT—coronary artery disease	2.62e-06	5.12e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AGT—coronary artery disease	2.6e-06	5.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.58e-06	5.04e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—coronary artery disease	2.57e-06	5.02e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.55e-06	4.99e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—coronary artery disease	2.54e-06	4.97e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOA1—coronary artery disease	2.54e-06	4.96e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOA1—coronary artery disease	2.51e-06	4.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.47e-06	4.83e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.47e-06	4.83e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—coronary artery disease	2.45e-06	4.79e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—coronary artery disease	2.43e-06	4.75e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.41e-06	4.71e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	2.4e-06	4.69e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—POMC—coronary artery disease	2.4e-06	4.69e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—coronary artery disease	2.37e-06	4.64e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—coronary artery disease	2.34e-06	4.58e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—POMC—coronary artery disease	2.34e-06	4.57e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	2.32e-06	4.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—coronary artery disease	2.3e-06	4.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—coronary artery disease	2.28e-06	4.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—coronary artery disease	2.24e-06	4.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.23e-06	4.37e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.22e-06	4.34e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.22e-06	4.33e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—POMC—coronary artery disease	2.2e-06	4.31e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.2e-06	4.3e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.19e-06	4.28e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—POMC—coronary artery disease	2.19e-06	4.27e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—coronary artery disease	2.18e-06	4.27e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—coronary artery disease	2.17e-06	4.24e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAT—coronary artery disease	2.16e-06	4.22e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.14e-06	4.19e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—coronary artery disease	2.13e-06	4.17e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	2.11e-06	4.12e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOB—coronary artery disease	2.1e-06	4.1e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.09e-06	4.09e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—coronary artery disease	2.04e-06	3.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.04e-06	3.99e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—coronary artery disease	2.01e-06	3.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPL—coronary artery disease	2e-06	3.91e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—coronary artery disease	1.99e-06	3.9e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.95e-06	3.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.95e-06	3.81e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.92e-06	3.76e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.91e-06	3.74e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—coronary artery disease	1.91e-06	3.73e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CD36—coronary artery disease	1.9e-06	3.72e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.88e-06	3.67e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—coronary artery disease	1.87e-06	3.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.8e-06	3.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.79e-06	3.5e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.76e-06	3.44e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.75e-06	3.43e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.74e-06	3.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AGT—coronary artery disease	1.71e-06	3.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—coronary artery disease	1.68e-06	3.28e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.66e-06	3.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.52e-06	2.98e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.46e-06	2.86e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—POMC—coronary artery disease	1.44e-06	2.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.35e-06	2.64e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.32e-06	2.58e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—coronary artery disease	1.31e-06	2.57e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.26e-06	2.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.24e-06	2.43e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.18e-06	2.3e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.15e-06	2.25e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.15e-06	2.24e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.08e-06	2.11e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—coronary artery disease	1.08e-06	2.1e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.07e-06	2.1e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—coronary artery disease	9.61e-07	1.88e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—coronary artery disease	9.38e-07	1.83e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—coronary artery disease	8.84e-07	1.73e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—coronary artery disease	8.76e-07	1.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.07e-07	1.38e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—coronary artery disease	5.78e-07	1.13e-05	CbGpPWpGaD
